Quadrivalent influenza vaccine (split virion, inactivated) suspension for injection 0.5ml pre-filled syringes Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

quadrivalent influenza vaccine (split virion, inactivated) suspension for injection 0.5ml pre-filled syringes

split virion, inactivated) suspension for injection 0.5ml pre-filled syringes (sanofi - influenza virus split virion - suspension for injection

Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) Evropska unija - angleščina - EMA (European Medicines Agency)

adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)

glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human - vaccines - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official guidance.

Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) Evropska unija - angleščina - EMA (European Medicines Agency)

adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)

glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human, immunization, disease outbreaks - vaccines, - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official guidance.,

Intanza Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

intanza

sanofi-aventis new zealand limited - influenza virus haemagglutinin 15ug (a h1n1 - strain to be confirmed prior to marketing); influenza virus type a haemagglutinin 15ug (h3n2 - strain to be confirmed prior to marketing); influenza virus type b haemagglutinin 15ug (strain to be confirmed prior to marketing) - suspension for injection - 15 mcg - active: influenza virus haemagglutinin 15ug (a h1n1 - strain to be confirmed prior to marketing) influenza virus type a haemagglutinin 15ug (h3n2 - strain to be confirmed prior to marketing) influenza virus type b haemagglutinin 15ug (strain to be confirmed prior to marketing) excipient: dibasic sodium phosphate dihydrate hydrochloric acid monobasic potassium phosphate potassium chloride sodium chloride sodium hydroxide water for injection

Vaxigrip suspension for injection in prefilled syringe.Influenza vaccine (split virion, inactivated) Malta - angleščina - Malta Medicines Authority

vaxigrip suspension for injection in prefilled syringe.influenza vaccine (split virion, inactivated)

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - influenza vaccine, split virion, inactivated - suspension for injection - influenza vaccine (split virion, inactivated) 15 µg - vaccines

Influenza vaccine (split virion, inactivated) suspension for injection 0.25ml pre-filled syringes Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

influenza vaccine (split virion, inactivated) suspension for injection 0.25ml pre-filled syringes

split virion, inactivated - influenza virus split virion - suspension for injection

Influenza vaccine (split virion, inactivated) suspension for injection 0.5ml pre-filled syringes Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

influenza vaccine (split virion, inactivated) suspension for injection 0.5ml pre-filled syringes

split virion, inactivated - influenza virus split virion - suspension for injection

Vaxigrip Tetra Suspension for injection / Quadrivalent influenza vaccine (split virion, inactivated) Malta - angleščina - Malta Medicines Authority

vaxigrip tetra suspension for injection / quadrivalent influenza vaccine (split virion, inactivated)

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - influenza vaccine, split virion, inactivated - suspension for injection in pre-filled syringe - influenza vaccine (split virion, inactivated) a/victoria/4897/2022 (h1n1) pdm09 - like strain (a/victoria/4897/2022 ivr-238 15 µg a/thailand/8/2022 (h3n2)-like strain (a/california/122/2022, san-022) 15 µg b/austria/1359417/2021-like strain (b/michigan/01/2021, wild type) 15 µg b/phuket/3073/2013 - like strain (b/phuket/3073/2013, wild type) 15 µg - vaccines

Trivalent influenza vaccine (split virion, inactivated) High Dose suspension for injection 0.5ml pre-filled syringes Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

trivalent influenza vaccine (split virion, inactivated) high dose suspension for injection 0.5ml pre-filled syringes

split virion, inactivated) high dose suspension for injection 0.5ml pre-filled syringes (sanofi pasteur - influenza virus inactivated split (h1n1, h3n2-like, b/brisbane/60/2008-like, strains) - suspension for injection

Adjupanrix Pandemic Influenza Vaccine (split virion inactivated AS03 adjuvanted) Singapur - angleščina - HSA (Health Sciences Authority)

adjupanrix pandemic influenza vaccine (split virion inactivated as03 adjuvanted)

glaxosmithkline pte ltd - split influenza virus, inactivated, containing antigen eqv a/vietnam/1194/2004 (h5n1) - injection, emulsion - split influenza virus, inactivated, containing antigen eqv a/vietnam/1194/2004 (h5n1) 3.75 µg haemagglutinin/dose